# A Personal Family Health Crisis Inspired This 105 Crore Portable ECG Startup

> Prompted by a family medical emergency, Neha Rastogi and Rahul Rastogi developed the portable SanketLife ECG device, building a business valued at 105 crore rupees.

**Type:** article · **Category:** Success Stories · **Published:** 2026-11-21 · **Source:** TrendKia
**Canonical:** https://trendkia.com/en/success-stories/ghar-ki-ek-mushkil-se-shuru-hua-safar-aaj-khada-kar-diya-105-crore-ka-business-61717 · **Language:** English
**Tags:** Agatsa Software, SanketLife, Neha Rastogi, Rahul Rastogi, Portable ECG, Startup Success, Sun Pharma

Often, the most groundbreaking commercial ideas do not emerge from corporate boardrooms or extensive market research, but rather from personal adversity. The journey of Agatsa Software, which has now grown into a business valued at 105 crore rupees, began precisely from a pressing health issue faced within a family home.

## Finding a Solution to a Domestic Challenge
The enterprise was co-founded by Neha Rastogi alongside her husband Rahul Rastogi. The catalyst for the venture occurred when Neha's father-in-law suffered a heart attack, leading to a situation where he had to make frequent, exhausting trips to the hospital for routine checkups. Seeking to eliminate the relentless hospital visits, the couple conceptualized a solution that would allow an electrocardiogram to be performed right at home. Their core vision was to shrink bulky hospital ECG machinery down to the size of a standard keychain, making cardiovascular monitoring accessible anywhere.

## The Birth of the Portable ECG Device
To realize this vision, Neha and her husband engineered a portable ECG device named SanketLife. Unlike traditional diagnostic equipment, this device operated entirely without conventional ECG wires and electrodes, capturing readings directly from the body and displaying the data seamlessly on a smartphone. The invention gained significant traction in the market because it effectively removed the logistical burden of regular monitoring for heart patients.

## Technical Background and Development Timeline
Both founders brought strong technical backgrounds to the venture, as Neha possessed deep expertise in software development while Rahul was skilled in electronics. Although they were previously employed at separate companies, witnessing their family's struggle prompted them to pool their skills and dedicate themselves fully to the project. They consulted numerous medical professionals and refined their concept into a working prototype. Development officially commenced in 2010, and the device was successfully introduced to the commercial market in 2017. The apparatus featured specialized sensors to capture readings through the fingertips and interface directly with mobile applications.

## Funding Milestones and Corporate Backing
Once the prototype was finalized, manufacturing required substantial financial backing. The Technology Development Board, a government institution, stepped in with funding of 3.91 crore rupees, enabling commercial production to begin. In August 2023, the firm secured Series A funding, which propelled its valuation to 105 crore rupees. Major pharmaceutical enterprise Sun Pharma invested 30 crore rupees into the company, acquiring a stake exceeding 26 percent. During the 2024-25 fiscal year, the company recorded a revenue of approximately 1 crore rupees.

## What this means for you
This entrepreneurial milestone carries significant implications for the domestic healthcare monitoring sector and families managing chronic cardiac conditions.

- **Healthcare Access:** Patients will no longer need to make frequent hospital visits for routine monitoring, saving considerable time and travel expenses.
- **Medical Devices:** The availability of portable diagnostic tools makes preliminary health assessments much more accessible during daily routines.
- **Investment Trends:** Emerging medical technology startups can anticipate increased financial backing and strategic partnerships from major pharmaceutical firms.
- **Daily Monitoring:** Families dealing with heart conditions gain the ability to track vitals at home, reducing anxiety associated with sudden health scares.

## Why this happened
The genesis of this business stems from personal necessity, while its subsequent commercial scale-up was driven by technical expertise and strategic financial backing.

- **Personal Catalyst:** The necessity for regular cardiac monitoring following a family heart attack directly inspired the invention of a portable diagnostic solution.
- 
The founders' professional backgrounds in software development and electronics engineering enabled them to successfully design and prototype the wireless device.

**Government Grant:** Early-stage financial support of 3.91 crore rupees from the Technology Development Board facilitated the transition into commercial manufacturing.
- **Strategic Investment:** Series A funding in August 2023, augmented by a 30 crore rupee investment from Sun Pharma, propelled the overall valuation to 105 crore rupees.

## Questions & Answers

### 1. Who founded Agatsa Software?
The company was founded by Neha Rastogi alongside her husband Rahul Rastogi.

### 2. What is the name of their flagship product?
The portable ECG device developed by them is named SanketLife.

### 3. What inspired the creation of this business idea?
The concept originated from the recurring hospital visits required after Neha's father-in-law suffered a heart attack.

### 4. When was the device first introduced to the market?
Development began in 2010, and the device was officially launched in the market in 2017.

### 5. How much initial government funding did the company receive?
The Technology Development Board provided a fund of 3.91 crore rupees for manufacturing.

### 6. Which major pharmaceutical company invested in the startup?
Sun Pharma invested 30 crore rupees in the company, acquiring over a 26 percent stake.

### 7. What is the current valuation of the company?
Agatsa Software has reached a valuation of 105 crore rupees following its Series A funding.

### 8. What was the company's revenue for the 2024-25 fiscal year?
The firm recorded a revenue of approximately 1 crore rupees during the 2024-25 financial year.

## Inspiration & Lessons
The entrepreneurial journey of Neha and Rahul Rastogi offers valuable lessons for innovators seeking to transform personal challenges into impactful ventures.

- **Convert Adversity into Innovation:** Difficult personal experiences and domestic hurdles can serve as the primary motivation for creating practical market solutions.
- **Leverage Core Skills:** Combining professional expertise in distinct technical fields allows founders to develop functional and sophisticated product prototypes.
- **Maintain Long-Term Persistence:** The multi-year timeline from conceptualization in 2010 to market release in 2017 demonstrates that complex innovations require patience.
- **Secure Strategic Support:** Utilizing government grants and partnering with established industry players provides the necessary momentum for commercial scaling.

---
_TrendKia — Har trend, sabse pehle.. Machine-readable view; canonical HTML at the URL above._